CE Schedule

CE Schedule

9:30 am
REGISTRATION DESK OPENS
Planet Hollywood Las Vegas, Conference Center
11:00 am
CONTRACEPTION UPDATE: WHAT'S NEW
Kathleen Besinque, PharmD, MSEd, FCSHP, FASHP, FCPhA, NCMP, and Sarah McBane, PharmD, CDE, BCPS, FCCP, FCPhA, APh

Click for Description & Learning Objectives

Description: Access to reproductive health care is a critical component of well-being. Pharmacists are positioned to provide reproductive healthcare in an accessible setting. This interactive lecture will address common reproductive health care needs in order to decrease the gaps in access to contraception and help prevent unintended pregnancy. New methods including the nonprescription hormonal contraceptive will be discussed.

Learning Objectives:
1. Discuss rates of unintended pregnancy and contraceptive use in the U.S.
2. Compare the contraception options available in the US including the recently approved OTC hormonal product.
3. Apply evidenced‐based guidelines to contraceptive provision using the CDC MEC.
4. Provide resources and referral to persons seeking care for reproductive health-related conditions.

Location: WILSHIRE A

1.0 CE Hour UAN: 0113-0000-24-018-L01-P; 0113-0000-24-018-L01-T
11:00 am
MULTIDISCIPLINARY FALL RISK ASSESSMENT AND INTERVENTIONS IN COMMUNITY DWELLING OLDER ADULTS
Gail Orum, PharmD, BCGP, and Daniel Kudo, PharmD, FCSHP, APh

Click for Description & Learning Objectives

Description: This session will focus on the role of pharmacists in reducing fall risk in older adults through reviewing current trends in falls, identifying pharmacy specific resources and tools for fall risk assessment, and exploring the outcomes of an existing falls intervention program. Finally, the session will culminate with a discussion of how pharmacists can utilize resources to educate patients and caregivers to aid in mitigating fall risk in older adults.

Learning Objectives:
1. Identify risk factors, incidence, and consequences of falls in older adults.
2. Describe and employ the use of the CDC STEADI Rx Community Pharmacy Algorithm and the Community Pharmacy Fall Risk Checklist.
3. Describe the outcomes of an existing falls intervention program.
4. Identify methods and resources to educate patients and caregivers to mitigate fall risk.

Location: SUNSET 5

1.0 CE Hour UAN: 0113-0000-24-003-L05-P; 0113-0000-24-003-L05-T
11:00 am
PHARMACISTS ROLE IN THE PREVENTION OF MENTAL HEALTH RELAPSE: LONG-ACTING INJECTABLE ANTIPSYCHOTICS
Jennifer Courtney, PharmD, BCACP, FCPhA, BS

Click for Description & Learning Objectives

Description: This session will cover the pharmacist’s role in providing long-acting injectable antipsychotics in the ambulatory and community pharmacy setting.

Learning Objectives:
1. Describe the role of the pharmacist in LAI antipsychotic administration in the ambulatory and community pharmacy setting.
2. Identify and compare the FDA approved long-acting injectable antipsychotics (LAIAs) including their indications, mechanism of action, dosing and frequency, route of administration, preparation, missed doses, requirements for oral supplementation, and storage.
3. Outline policies, procedures, workflow, reimbursement, inventory, and provider communication and feedback processes for administering long-acting injectables (LAIs).

Location: SUNSET 3

1.0 CE Hour UAN: 0113-0000-24-002-L01-P; 0113-0000-24-002-L01-P
12:15 pm
PRESCRIBING SAFE JOURNEYS: UPDATED TRAVEL RECOMMENDATIONS FROM THE CDC YELLOW BOOK 2024
Edith Mirzaian, PharmD, BCACP, Nicki Mashayekan, PGY1 Community-Based Pharmacy, and Ishani Wewala Panditha, PGY1 Community-Based Pharmacy

Click for Description & Learning Objectives

Description: The CDC Yellow Book is a comprehensive, up-to-date reference providing the information necessary to address health risks associated with international travel across the globe. In this session, we’ll review the CDC Yellow Book 2024 updates on disease-specific prevention and treatment recommendations in relation to the previous edition and highlight key recommendation changes and additions.

Learning Objectives:
1. Identify current resources and guidelines for providing travel vaccines, precautions, and recommendations.
2. Discuss the 2024 CDC Yellow Book updates and changes to travel health recommendations.
3. Describe the new precautions for international travelers during the COVID-19 pandemic.
4. Apply new guideline recommendations to case-based scenarios.

Location: Wilshire A

1.0 CE Hour UAN: 0113-0000-24-006-L06-P; 0113-0000-24-006-L06-T
12:15 pm
PSYCHOTROPIC MEDICATIONS FOR THE NON-SPECIALISTS
Jody Jacobson Wedret, RPh, FASHP, FCSHP

Click for Description & Learning Objectives

Description: This session will explore the four most common psychiatric conditions, the symptoms that define them and the medications that treat them. It will also explore some of the characteristics of these patients which when better understood can help the pharmacist better understand and serve them.

Learning Objectives:
1. Match basic psychiatric symptoms with appropriate medication classifications.
2. State realistic expectations for outcomes from agents used in psychiatry.
3. Identify drug classes, agents and usual side effects.
4. Develop basic skill sets to address psychiatric concerns.
5. Recognize community resources to help patients with psychiatric disorders.

Location: SUNSET 5

1.0 CE Hour UAN: 0113-0000-24-004-L06-P; 0113-0000-24-004-L06-T
12:15 pm
TO THE POINT: ADVANCED INJECTION TECHNIQUES FOR VACCINATIONS AND MEDICATION ADMINISTRATION
Richard Dang, PharmD, APh, BCACP, Allison Chacon, PharmD, APh, and Terrance Ito, NP-C

Click for Description & Learning Objectives

Description: Pharmacists are essential vaccination providers who are trained to administer vaccines by either intramuscular or subcutaneous injection at traditional sites of injection. This session will review advanced injection site techniques, for vaccines and medication administration, using various routes of administration (such as intramuscular, subcutaneous, intradermal) and the alternate sites of injection (such as vastus lateralis, gluteal, and forearm).

Learning Objectives:
1. List and describe the steps for intramuscular, subcutaneous, and intradermal injection. 2. Identify alternate site locations for injections, such as the vastus lateralis, gluteal, or forearm. 3. Identify best practices to reduce errors related to the handling and administration of vaccines.

Location: SUNSET 3

1.0 CE Hour UAN: 0113-0000-23-014-L01-P; 0113-0000-23-014-L01-T
1:30 pm
<51>ANTIMICROBIAL EFFECTIVENESS TESTING, <71>STERILITY TESTING AND RAPID STERILITY TESTING
Brian Kelley

Click for Description & Learning Objectives

Description: This session will cover USP 51 Antimicrobial Effectiveness Testing, USP 71 Sterility Testing, and Rapid Sterility and how these tests apply to implementing beyond use dating assignments per the revised USP chapters. Participants will learn when to test, what to test, how to interpret the results, the limits of the test and specific actions required when a preparation does not meet specifications.

Learning Objectives:
1. Discuss antimicrobial preservative selection in compounded preparations and factors that may influence their effectiveness.
2. Explain antimicrobial effectiveness testing per USP 51 for non-sterile and sterile preparations.
3. Identify sterility testing per USP 797 for compounded sterile preparations, including practical examples.
4. Define rapid sterility methods and explain FDA and USP requirements for rapid sterility method validation.
5. Outline Factors to consider when implementing rapid sterility methods.

Location: WILSHIRE A

1.0 CE Hour UAN: 0113-0000-24-001-L99-P; 0113-0000-24-001-L99-T
1:30 pm
ANNUAL WELLNESS VISITS: ARE YOU READY TO MAKE SOME MONEY?
Albert Bach, PharmD, and Jelena Lewis, PharmD

Click for Description & Learning Objectives

Description: This session will cover Medicare annual wellness visits and how pharmacists are positioned to conduct and implement this revenue-generating service in their practice settings. Tips on how to get started and deliver this service will also be reviewed.

Learning Objectives:
1. Define Medicare’s Annual Wellness Visit and its requirements.
2. Justify how pharmacists can play a role in conducting an Annual Wellness Visit.
3. List the steps to conduct an Annual Wellness Visit.
4. Propose how to implement Annual Wellness Visits into various pharmacy practice settings.

Location: SUNSET 5

1.0 CE Hour UAN: 0113-0000-24-008-L04-P; 0113-0000-24-008-L04-T
1:30 pm
OPTIMIZING CANCER PATIENTS SUPPORTIVE CARE REGIMENS IN THE COMMUNITY SETTING
Fouad Boulbol, PharmD

Click for Description & Learning Objectives

Description: This presentation would briefly review the updated NCCN Supportive Care guidelines in antiemesis, anti-infectives, as well as growth factor support. The goal is to reinforce guideline driven recommendations to empower pharmacists to recognize different supportive care regimens in order to educate their patients efficiently.

Learning Objectives:
1. Demonstrate an understanding on the class of medications used for prevention and treatment of chemotherapy induced nausea & vomiting, accompanied with clinical pearls of each class based on updated NCCN guidelines. 2. Demonstrate an understanding of anti-infectives utilized in patient’s treatments, their dosing, duration, and unique considerations based on updated NCCN guidelines. 3. Describe the purpose of growth factor support, and its role in cancer care.

Location: SUNSET 3

1.0 CE Hour UAN: 0113-0000-24-007-L99-P; 0113-0000-24-007-L99-T
2:45 pm
CANCER: HOW IS THIS AFFECTED BY THE INTESTINAL MICROBIOTA?
Cynthia L. Lieu, PharmD

Click for Description & Learning Objectives

Description: Approximately 40% of men and women will be diagnosed with cancer during their lifetime. Learn about how the intestinal microbiota affects the development of cancer, how the intestinal microbiota can affect the efficacy and toxicities associated with anti-cancer therapies and interventions that can modify the intestinal microbiota.

Learning Objectives:
1. Discuss the relationship between the intestinal microbiota and cancer development.
2. Discuss the relationship between the intestinal microbiota and response to anti-cancer therapies.
3. Discuss how modifications of the intestinal microbiota may impact the response to anti-cancer therapies.

Location: SUNSET 5

1.0 CE Hour UAN: 0113-0000-24-011-L01-P; 0113-0000-24-011-L01-T
2:45 pm
SGLT“2” GOOD TO BE TRUE? RENAL OUTCOMES OF SGLT2 INHIBITORS
Kanika Bhandari, PharmD

Click for Description & Learning Objectives

Description: This presentation will outline current guideline and expert recommendations on SGLT2 inhibitors in kidney disease and delve into the data that backs these claims by reviewing landmark trials. Through this knowledge-based presentation, pharmacists will learn which patient populations are most optimal to start on SGLT2 inhibitors.

Learning Objectives:
1. Outline current guidelines and the role of SGLT2 inhibitors in kidney disease.
2. Review the literature regarding SGLT2 inhibitors and their place in patients with kidney disease.
3. Define optimal patients to initiate on SGLT2 inhibitors.

Location: WILSHIRE A

1.0 CE Hour UAN: 0113-0000-24-009-L01-P; 0113-0000-24-009-L01-T
2:45 pm
WHAT ARE MY OPTIONS TO LOSE WEIGHT - MEDICATIONS OR SURGERY?
Hyma Gogineni, PharmD, MSc, BCACP, APh, TTS

Click for Description & Learning Objectives

Description: Pharmacists will be able to provide more insights for patients seeking weight loss options between surgery and new pharmacological agents.

Learning Objectives:
1. Describe the health consequences of obesity and benefits of weight loss.
2. Discuss pharmacotherapy options to treat obesity in the US.
3. Discuss appropriate dosing, pros and cons of each of anti-obesity agent given a patient case.
4. Discuss pharmacotherapy options vs weight loss surgery.
5. Describe the role of therapeutic lifestyle for overall health.

Location: SUNSET 3

1.0 CE Hour UAN: 0113-0000-24-010-L01-P; 0113-0000-24-010-L01-T
4:00-6:30 pm
EXHIBIT HALL, POSTER SESSIONS & PRODUCT THEATER
Celebrity 4
4:30-5:30 pm
OPENING RECEPTION
Exhibit Hall (Celebrity 4)
6:00 pm
REGISTRATION DESK CLOSES
Planet Hollywood Las Vegas, Conference Center
8:00-9:30 pm
HALL OF FAME RECEPTION (requires ticket purchase)
London Club
9:30 am
REGISTRATION DESK OPENS
Planet Hollywood Las Vegas, Conference Center
1:30 pm
THE INS AND OUTS OF HRT, IT’S NOT JUST FOR HOT FLASHES
Ranel Larsen, PharmD, RPh, and Erin Michael, MBA, MS, CPhT, FAPC, PCCA

Click for Description & Learning Objectives

Description: During this session, the speakers will discuss the differences between bioidentical and synthetic hormones and the role of hormone therapy in maintaining overall health and well-being.

Learning Objectives:
1. Distinguish between bioidentical and synthetic hormones.
2. Understand the connection between hormones and common conditions such as genitourinary health, sleep disturbances, mental health and weight loss.
3. Understand the importance of an individualized approach to hormone therapy.
4. Identify the role of hormone therapy in maintaining overall health and well‐being.
5. Describe techniques for marketing hormone replacement therapy in the pharmacy to patients and prescribers

Location: MELROSE 1

1.0 CE Hour UAN: 0113-0000-24-024-L01-P; 0113-0000-24-024-L01-T
2:45 pm
CREATING A CULTURE OF COMPLIANCE
Linda Panofsky, PharmD

Click for Description & Learning Objectives

Description: Meeting resistance in the workplace to necessary compliance tasks? Come learn how to not only create a culture of compliance in your pharmacy workplace, but how to nurture it through using motivation and powers of positive persuasion.

Learning Objectives:
1. Describe the current state of healthcare compliance from regulatory and accreditation bodies.
2. Understand the psychology and neuroscience behind persuasion and motivation.
3. Recognize the key contributors to a successful compliance program.
4. List the fundamental practices in a strong culture of compliance.
5. Identify situations that present obstacles to a culture of compliance and how to mitigate them

Location: MELROSE 1

1.0 CE Hour UAN: 0113-0000-24-025-L04-P; 0113-0000-24-025-L04-T
4:00-6:30 pm
EXHIBIT HALL, POSTER SESSIONS & PRODUCT THEATER
Celebrity 4
4:30-5:30 pm
OPENING RECEPTION
Exhibit Hall (Celebrity 4)
6:00 pm
REGISTRATION DESK CLOSES
Planet Hollywood Las Vegas, Conference Center
9:30 am
REGISTRATION DESK OPENS
Planet Hollywood Las Vegas, Conference Center
2:45 pm
RESIDENCY INTERVIEWS: ARE YOU READY TO BE THE STAR?
Jelena Lewis, PharmD, and Laressa Bethishou , PharmD, APh, BCPS

Click for Description & Learning Objectives

Description: In this interactive session, the audience will learn about interview skills utilizing the STAR method. We will also touch upon goal setting and how this should be utilized when answering interview questions. Our focus will be on residency interviews.br>
Learning Objectives:
1. List the components of STAR method interview technique.
2. Describe how to utilize the STAR method during an interview.
3. Describe strategies to align interview responses with professional brand.
4. Identify pearls for a successful residency interview.

Location: MELROSE 3

4:00-6:30 pm
EXHIBIT HALL, POSTER SESSIONS & PRODUCT THEATER
Celebrity 4
4:30-5:30 pm
OPENING RECEPTION
Exhibit Hall (Celebrity 4)
6:00 pm
REGISTRATION DESK CLOSES
Planet Hollywood Las Vegas, Conference Center
7:00 am
REGISTRATION DESK OPENS
Planet Hollywood Las Vegas, Conference Center
8:00 am
CALIFORNIA PHARMACY LAW UPDATE: 2024, Q1 (NON-RECORDED)
Tony J. Park, PharmD, JD, and Anne Sodergren

Click for Description & Learning Objectives

Description: Join Board of Pharmacy Executive Director Anne Sodergren and CPhA General Counsel Tony J. Park, PharmD, JD, as they highlight changes in state and federal pharmacy laws for 2024. This session is an opportunity to identify and discuss overarching trends in the regulatory climate for California pharmacists.

Learning Objectives:
1. Describe changes in state and federal pharmacy laws for 2024.
2. Explain overarching trends in the regulatory climate for California pharmacists.
3. Summarize current pharmacy standards of practice.
4. Identify resources for staying current on regulatory issues.

Location: CELEBRITY 1

1.5 CE Hours UAN: 0113-0000-24-012-L03-P; 0113-0000-24-012-L03-T
9:30-10:30 am
ANNUAL BUSINESS MEETING
Celebrity 1
10:45 am
ANNUAL IMMUNIZATION UPDATE: 2024
Richard Dang, PharmD, APh, BCACP, and Jeff Goad, PharmD, MPH, FISTM, FAPHA, FCSHP, FCPhA

Click for Description & Learning Objectives

Description: An up-to-date knowledge of CDC immunization recommendations is essential for pharmacists initiating and administering vaccines in California. This program will focus on key changes to the CDC’s annual immunization schedules and new vaccine products approved in the last year.

Learning Objectives:
1. Review and interpret important changes to ACIP recommendations and the CDC’s immunization schedules for adults and children in the United States.
2. Review newly licensed vaccine products and examine data on efficacy and safety.
3. Examine information about the efficacy and safety of newly licensed vaccine products.
4. Assess patient profiles and develop recommendations for immunizations based on age, medical indications, or other risk factors.

Location: MELROSE 3

1.0 CE Hour UAN: 0113-0000-24-016-L06-P; 0113-0000-24-016-L06-T
10:45 am
IMPACT OF EXPLICIT AND IMPLICIT BIAS IN HEALTH CARE
Marisella Guerrero, PharmD

Click for Description & Learning Objectives

Description: This session will cover different types of bias, where biases stem from, examine the implications of bias in health care, help individuals identify some of their own biases and discuss ways in which biases can be mitigated.

Learning Objectives:
1. Describe various categories of bias and where they stem from.
2. List examples of the bias that exists in health care.
3. Describe how explicit and implicit bias contribute to health care disparities.
4. Identify and reflect on one’s own biases.
5. Describe methods used to mitigate bias.

Location: SUNSET 5

1.0 CE Hour UAN: 0113-0000-24-014-L99-P; 0113-0000-24-014-L99-T
10:45 am
QUALITY IMPROVEMENT AND PHARMACY: FUNDAMENTALS
George Do, PharmD

Click for Description & Learning Objectives

Description: This session will educate participants within pharmacy about the broad concepts of quality improvement and tools available for quick implementation.

Learning Objectives:
1. Define Quality Improvement.
2. Understand role and influence of other members of interdisciplinary team.
3. Determine what Quality Improvement tools are best in various scenarios.
4. Reproduce results in clinical studies to specific work settings.
5. Relate obstacles to quality improvement.

Location: SUNSET 3

1.0 CE Hour UAN: 0113-0000-24-013-L04-P; 0113-0000-24-013-L04-T
12:00-1:30 pm
AWARDS CEREMONY WITH SPECIAL GUEST SHENG WANG
Celebrity 1
1:30-4:00 pm
EXHIBIT HALL, POSTER SESSIONS & PRODUCT THEATER (lunch provided)
Celebrity 4
4:00 pm
BEYOND STATINS: A REVIEW OF NOVEL LIPID-LOWERING THERAPIES
Jennifer Ko, PharmD, MPH, BCACP, APH, and Laura Tsu, PharmD, BCPS, BCGP, BCCP

Click for Description & Learning Objectives

Description: This session will discuss novel lipid-lowering therapies and the evidence behind their clinical benefits and drawbacks using guideline and consensus recommendations.

Learning Objectives:
1. Explain the pathophysiology of atherosclerotic cardiovascular disease and familial hypercholesterolemia.
2. Summarize the outcomes of the ODYSSEY, FOURIER, ORION, and CLEAR Outcomes trials.
3. Compare the clinical benefits and drawbacks of PCSK9 inhibitors, siRNA, and ACL inhibitor to statin therapy using guideline and consensus recommendations.
4. Recommend the use of novel antilipidemic agents based on a patient case.

Location: SUNSET 3

1.0 CE Hour UAN: 0113-0000-24-015-L01-P; 0113-0000-24-015-L01-T
4:00 pm
NEW UPDATES ON ASTHMA AND COPD
Brian Ma, PharmD, BCPS, and Michelle Chu, PharmD, BCACP, APh

Click for Description & Learning Objectives

Description: This course will provide an overview of the new 2023 asthma GINA and 2023 COPD GOLD guidelines. New changes in clinical practice will be discussed.

Learning Objectives:
1. Describe the safety, effectiveness, and evidence behind the new ICS-SABA inhaler.
2. Assess the appropriateness of a patient’s current asthma pharmacotherapy and track category.
3. Compare differences in the ABCD COPD Assessment Tool and the ABE COPD Assessment Tool.
4. Apply GOLD guidelines to recommend appropriate pharmacotherapy after COPD exacerbation.
5. Assess COPD exacerbation characteristics with new GOLD guidelines recommendations.

Location: MELROSE 3

1.0 CE Hour UAN: 0113-0000-24-017-L01-P; 0113-0000-24-017-L01-T
5:00 pm
REGISTRATION DESK CLOSES
Planet Hollywood Las Vegas, Conference Center
5:00-6:00 pm
MEDICATION ABORTION CARE AT THE PHARMACY
Sally Rafie, PharmD, BCPS, APh, FCCP, FCPhA

Click for Description & Learning Objectives

Description: Offered by Birth Control Pharmacist in partnership with the California Pharmacists Association (CPhA) and the CPhA Foundation, the goal of this program is to prepare pharmacists and pharmacy technicians to participate in patient-centered medication abortion care. This program will prepare participants to provide accurate information about medication abortion to patients and develop medication abortion services at their practice sites, including how to obtain certification to dispense mifepristone, in accordance with the FDA Mifepristone REMS program.

Learning Objectives:
1. Demonstrate an understanding of the current climate surrounding medication abortion services and barriers to access.
2. Describe the process of obtaining pharmacy certification to dispense mifepristone.
3. Describe pharmacist roles and procedures for dispensing mifepristone under the FDA Mifepristone REMS program.
4. Demonstrate accurate patient counseling about the mechanism, effectiveness, expectations, instructions for use, and adverse event management for mifepristone and misoprostol.

Location: Melrose 3

1.0 CE Hour UAN: # To Be Added Soon
8:30-10:30 pm
LIGHTS< CAMERA< ACTION! RECEPTION (21+ only)
London & Gallery Club
7:00 am
REGISTRATION DESK OPENS
Planet Hollywood Las Vegas, Conference Center
9:30-10:30 am
ANNUAL BUSINESS MEETING
Celebrity 1
10:45 am
RECENT COUNTERFEIT MEDICINES AND WHAT YOU NEED TO KNOW ABOUT DSCSA
Shabbir Imber Safdar, BS

Click for Description & Learning Objectives

Description: This course will review a recent counterfeit case, show how it can be foiled by checking the DSCSA serial numbers on medication and then explain the details of the DSCSA.

Learning Objectives:
1. KNOW how to confirm a vendor has a wholesale pharmaceutical license.
2. IDENTIFY and EXPLAIN the four elements on the DSCSA portion of the label.
3. EXPLAIN how the technology of the DSCSA works.
4. IDENTIFY the warning signs of a vendor selling illegitimate product.

Location: MELROSE 1

1.0 CE Hour UAN: 0113-0000-24-027-L04-P; 0113-0000-24-027-L04-T
12:00-1:30 pm
AWARDS CEREMONY WITH SPECIAL GUEST SHENG WANG
Celebrity 1
1:30-4:00 pm
EXHIBIT HALL, POSTER SESSIONS & PRODUCT THEATER (lunch provided)
Celebrity 4
4:00 pm
SLOW THE CHURN - REAP THE BENEFITS OF REDUCED EMPLOYEE TURNOVER
Michael Negrete, PharmD, and Nancy Alvarez, PharmD

Click for Description & Learning Objectives

Description: It’s been estimated that losing an employee can cost a company one half to two times that employee’s annual salary, not to mention the effort, time and stress for those tasked with filling vacancies. In this program, attendees will learn the major causes of employee turnover and how to assess and address identified risks to maintain team members.

Learning Objectives:
1. Summarize the literature detailing the problem and cost of employee turnover.
2. Identify the most common factors that drive turnover.
3. List the 10 questions to ask to identify which factors are most significantly contributing to a team’s risk of high turnover.
4. Identify action steps to address areas of identified risk.

Location: MELROSE 1

1.0 CE Hour UAN: 0113-0000-24-026-L04-P; 0113-0000-24-026-L04-T
5:00 pm
REGISTRATION DESK CLOSES
Planet Hollywood Las Vegas, Conference Center
5:00-6:00 pm
MEDICATION ABORTION CARE AT THE PHARMACY
Sally Rafie, PharmD, BCPS, APh, FCCP, FCPhA

Click for Description & Learning Objectives

Description:Offered by Birth Control Pharmacist in partnership with the California Pharmacists Association (CPhA) and the CPhA Foundation, the goal of this program is to prepare pharmacists and pharmacy technicians to participate in patient-centered medication abortion care. This program will prepare participants to provide accurate information about medication abortion to patients and develop medication abortion services at their practice sites, including how to obtain certification to dispense mifepristone, in accordance with the FDA Mifepristone REMS program.

Learning Objectives:
1. Demonstrate an understanding of the current climate surrounding medication abortion services and barriers to access.
2. Describe the process of obtaining pharmacy certification to dispense mifepristone.
3. Describe pharmacist roles and procedures for dispensing mifepristone under the FDA Mifepristone REMS program.
4. Demonstrate accurate patient counseling about the mechanism, effectiveness, expectations, instructions for use, and adverse event management for mifepristone and misoprostol.

Location: Melrose 3

1.0 CE Hour UAN: # To Be Added Soon
6:00-7:30 pm
Pharmacy Ownership SIG Meeting
Melrose 1
8:30-10:30 pm
LIGHTS< CAMERA< ACTION! RECEPTION (21+ only)
London & Gallery Club
7:00 am
REGISTRATION DESK OPENS
Planet Hollywood Las Vegas, Conference Center
8:30 am
CAREER ROUNDTABLE
Melissa Kimura, PharmD, and Vivian Truong, PharmD

Click for Description & Learning Objectives

Description: This student session will provide pharmacy students the opportunity to connect with pharmacists in different practice settings (traditional and non traditional). The aim of the session is for students to hear and think of other possible career paths before them in a round table/career speed dating format. Students will be able to listen to an overview of each pharmacists, the path they took to be in the current practice setting, and an opportunity for Q&A.

Location: WILSHIRE A

9:30-10:30 am
ANNUAL BUSINESS MEETING
Celebrity 1
10:45 am
STRATEGIES FOR SUCCESS: WHAT'S NEXT AFTER GRADUATION?
Samantha Teshima, PharmD, and Goldie Yvari, PharmD

Click for Description & Learning Objectives

Description: This program is targeted specifically towards pharmacy students ‐ utilizing all the resources available to you, and maximizing your pharmacy school experience. This presentation will discuss the importance of leadership and how to find meaningful opportunities, leverage tips and tricks on how to study while working in the pharmacy, provide insight into navigating post‐graduate opportunities, a timeline on how to apply to residency, and an overview on what to expect on the NAPLEX.

Learning Objectives:
1. Identify gaps in learning experiences and create a more balanced pharmacy school plan.
2. Recall important “high‐yield” clinical topics in the workplace that are tested on pharmacy board exams.
3. Demonstrate critical thinking in working through a real‐life example of reinforcing knowledge in the workplace.

Location: WILSHIRE A

12:00-1:30 pm
AWARDS CEREMONY WITH SPECIAL GUEST SHENG WANG
Celebrity 1
1:30-4:00 pm
EXHIBIT HALL, POSTER SESSIONS & PRODUCT THEATER (lunch provided)
Celebrity 4
4:00-6:00 pm
QUIZ BOWL & FILM FESTIVAL
Celebrity 1
5:00 pm
REGISTRATION DESK CLOSES
Planet Hollywood Las Vegas, Conference Center
8:30-10:30 pm
LIGHTS< CAMERA< ACTION! RECEPTION (21+ only)
London & Gallery Club
8:30 am
DISPARITIES AMONG PATIENTS USING THE END-OF-LIFE OPTION ACT
Jim Pinder, PhD, JD, MBA

Click for Description & Learning Objectives

Description: This session will cover how data from the California Department of Public Health indicates disparities among patients using the End-of-Life Option Act. Your participation in this presentation will explore the logic behind these disparities and shape future research on this topic.

Learning Objectives:
1. List the requirements of the End-of-Life Option Act.
2. Describe the demographic trends of the End-of-Life Option Act patient population since its implementation in 2016.
3. Articulate possible reasons for these disparities.

Location: SUNSET 5

1.0 CE Hour UAN: 0113-0000-24-019-L03-P; 0113-0000-24-019-L03-T
8:30 am
GLUCOSE ON THE GO: USING CONTINUOUS GLUCOSE MONITORING TO REACH GLYCEMIC GOALS
Rory E. Kim, PharmD, MACM, BCACP, Michelle Chu, PharmD, BCACP, APh, and Carla Blieden, PharmD, MP

Click for Description & Learning Objectives

Description: Continuous glucose monitoring (CGM) has brought a revolutionary shift in diabetes management, benefiting both patients and healthcare providers by eliminating the need for frequent finger sticks and offering a comprehensive glucose profile. In this educational session, the pharmacy team will gain the necessary expertise to initiate and interpret CGM for patients in any pharmacy setting, enabling them to better support diabetes care and improve patient outcomes.

Learning Objectives:
1. Describe the benefits of continuous glucose monitoring devices in the management of type 2 diabetes.
2. Identify appropriate indications for continuous glucose monitoring in diabetes management.
3. Demonstrate proficiency in counseling for a patient on the appropriate use of a continuous glucose monitoring device, including sensor application, setting up reader/application, and alerts.
4. Describe the use of the ambulatory glucose profile (AGP) in setting glycemic treatment goals and adjusting diabetes therapy.
5. Given a patient’s CGM data, utilize the AGP to analyze trends and formulate a treatment plan.

Location: WILSHIRE A

1.0 CE Hour UAN: 0113-0000-24-020-L01-P; 0113-0000-24-020-L01-T
8:30 am
WHEN CANNABIS IS MEDICINE: ITS PHYSIOLOGICAL IMPACTS AND CLINICAL APPLICATIONS
Jill Simonian, PharmD, Kari Franson PharmD, PhD, BCPP, Codi Peterson, PharmD, MS, Leah Johnson, PharmD, and Paul Lofholm, PharmD, FACA

Click for Description & Learning Objectives

Description: This presentation will explain how and why cannabis is used as a medicine, outlining the physiological activity of cannabis within the endocannabinoid system and clarifying the side effects and potential drug interactions of cannabis. Practical uses of cannabis, including dosing and monitoring, will be demonstrated, highlighting patient case scenarios.

Learning Objectives:
1. Define and describe the three primary components that constitute the endocannabinoid system.
2. Correlate the physiological action of cannabis with potential therapeutic uses.
3. Identify common and rare adverse effects of cannabis and evaluate drug interaction potential.
4. Devise a cannabis dosing, titration, and monitoring plan for a patient.

Location: SUNSET 3

1.0 CE Hour UAN: 0113-0000-24-028-L01-P; 0113-0000-24-028-L01-T
9:45 am
BURNOUT VS. MORAL INJURY: HOW THEY'RE DIFFERENT AND WHY IT MATTERS
Michael Negrete, PharmD, and Nancy Alvarez, PharmD

Click for Description & Learning Objectives

Description: Increasing workloads and resulting stresses on pharmacists have led to growing staffing shortages due to what many thought leaders are calling “burnout”. Unfortunately, what may actually be affecting many pharmacists is a phenomenon called “moral injury”. Conflating moral injury with burnout is problematic and dangerous as it fails to acknowledge the existential suffering and impact on individuals. This program will help attendees understand the difference between burnout and moral injury, and the distinct strategies for addressing each.

Learning Objectives:
1. Summarize the literature detailing pharmacist/technician “shortages” .
2. Compare and contrast the causes and symptoms of burnout vs. moral injury.
3. Describe the expected consequences for NOT addressing “moral injury” .
4. Compare and contrast the common interventions used to address burnout vs. moral injury.

Location: SUNSET 3

1.0 CE Hour UAN: 0113-0000-24-022-L04-P; 0113-0000-24-022-L04-T
9:45 am
FOREVER YOUNG: EMBRACING AGE-FRIENDLY HEALTH SYSTEMS FOR OPTIMAL GERIATRIC CARE
Christine Kim, PharmD, Tatyana Gurvich, PharmD, BCGP, APh, and Patrick Tabon, PharmD, MPH, APh, BCPS, BCGP, BCACP

Click for Description & Learning Objectives

Description: In this presentation, we will discuss implementing age-friendly health systems and incorporating the four evidence-based elements: What Matters, Medication, Mentation, and Mobility. These elements are essential for providing patient-centered care to our geriatric patients, prioritizing their unique needs, and ensuring high-quality outcomes.

Learning Objectives:
1. Identify the 4M’s of age-friendly health systems.
2. Discuss resources utilized to develop an age-friendly health system.
3. Outline various roles pharmacists can play in age-friendly health systems.
4. Implement age-friendly health systems in practice.

Location: WILSHIRE A

1.0 CE Hour UAN: 0113-0000-24-022-L04-P; 0113-0000-24-022-L04-T
9:45 am
OPIOID/TRAUMA DISCHARGE COUNSELING: THE PROCESS, THE "PERCS", AND NALOXONE
Amber Miller, PharmD, and Erin Bess, PharmD

Click for Description & Learning Objectives

Description: Participants in this learning activity will gain insights on how to implement an opioid discharge counseling service at a community institution, including provision of naloxone in-hand upon discharge.

Learning Objectives:
1. Describe the current state of opioid discharge counseling and naloxone distribution at your institution.
2. Identify potential opportunities for a novel opioid discharge counseling and naloxone distribution program at your institution.
3. Develop a plan to create a successful opioid discharge counseling and naloxone in-hand program.
4. Measure possible institutional benefits derived from an opioid discharge counseling and naloxone in-hand program.

Location: SUNSET 5

1.0 CE Hour UAN: 0113-0000-24-023-L01-P; 0113-0000-24-023-L01-T
8:30 am
DISPARITIES AMONG PATIENTS USING THE END-OF-LIFE OPTION ACT
Jim Pinder, PhD, JD, MBA

Click for Description & Learning Objectives

Description: This session will cover how data from the California Department of Public Health indicates disparities among patients using the End-of-Life Option Act. Your participation in this presentation will explore the logic behind these disparities and shape future research on this topic.

Learning Objectives:
1. List the requirements of the End-of-Life Option Act.
2. Describe the demographic trends of the End-of-Life Option Act patient population since its implementation in 2016.
3. Articulate possible reasons for these disparities.

Location: SUNSET 5

1.0 CE Hour UAN: 0113-0000-24-019-L03-P; 0113-0000-24-019-L03-T
8:30 am
GLUCOSE ON THE GO: USING CONTINUOUS GLUCOSE MONITORING TO REACH GLYCEMIC GOALS
Rory E. Kim, PharmD, MACM, BCACP, Michelle Chu, PharmD, BCACP, APh, and Carla Blieden, PharmD, MP

Click for Description & Learning Objectives

Description: Continuous glucose monitoring (CGM) has brought a revolutionary shift in diabetes management, benefiting both patients and healthcare providers by eliminating the need for frequent finger sticks and offering a comprehensive glucose profile. In this educational session, the pharmacy team will gain the necessary expertise to initiate and interpret CGM for patients in any pharmacy setting, enabling them to better support diabetes care and improve patient outcomes.

Learning Objectives:
1. Describe the benefits of continuous glucose monitoring devices in the management of type 2 diabetes.
2. Identify appropriate indications for continuous glucose monitoring in diabetes management.
3. Demonstrate proficiency in counseling for a patient on the appropriate use of a continuous glucose monitoring device, including sensor application, setting up reader/application, and alerts.
4. Describe the use of the ambulatory glucose profile (AGP) in setting glycemic treatment goals and adjusting diabetes therapy.
5. Given a patient’s CGM data, utilize the AGP to analyze trends and formulate a treatment plan.

Location: WILSHIRE A

1.0 CE Hour UAN: 0113-0000-24-020-L01-P; 0113-0000-24-020-L01-T
8:30 am
WHEN CANNABIS IS MEDICINE: ITS PHYSIOLOGICAL IMPACTS AND CLINICAL APPLICATIONS
Jill Simonian, PharmD, Kari Franson PharmD, PhD, BCPP, Codi Peterson, PharmD, MS, Leah Johnson, PharmD, and Paul Lofholm, PharmD, FACA

Click for Description & Learning Objectives

Description: This presentation will explain how and why cannabis is used as a medicine, outlining the physiological activity of cannabis within the endocannabinoid system and clarifying the side effects and potential drug interactions of cannabis. Practical uses of cannabis, including dosing and monitoring, will be demonstrated, highlighting patient case scenarios.

Learning Objectives:
1. Define and describe the three primary components that constitute the endocannabinoid system.
2. Correlate the physiological action of cannabis with potential therapeutic uses.
3. Identify common and rare adverse effects of cannabis and evaluate drug interaction potential.
4. Devise a cannabis dosing, titration, and monitoring plan for a patient.

Location: SUNSET 3

1.0 CE Hour UAN: 0113-0000-24-028-L01-P; 0113-0000-24-028-L01-T
9:45 am
BURNOUT VS. MORAL INJURY: HOW THEY'RE DIFFERENT AND WHY IT MATTERS
Michael Negrete, PharmD, and Nancy Alvarez, PharmD

Click for Description & Learning Objectives

Description: Increasing workloads and resulting stresses on pharmacists have led to growing staffing shortages due to what many thought leaders are calling “burnout”. Unfortunately, what may actually be affecting many pharmacists is a phenomenon called “moral injury”. Conflating moral injury with burnout is problematic and dangerous as it fails to acknowledge the existential suffering and impact on individuals. This program will help attendees understand the difference between burnout and moral injury, and the distinct strategies for addressing each.

Learning Objectives:
1. Summarize the literature detailing pharmacist/technician “shortages” .
2. Compare and contrast the causes and symptoms of burnout vs. moral injury.
3. Describe the expected consequences for NOT addressing “moral injury” .
4. Compare and contrast the common interventions used to address burnout vs. moral injury.

Location: SUNSET 3

1.0 CE Hour UAN: 0113-0000-24-022-L04-P; 0113-0000-24-022-L04-T
9:45 am
FOREVER YOUNG: EMBRACING AGE-FRIENDLY HEALTH SYSTEMS FOR OPTIMAL GERIATRIC CARE
Christine Kim, PharmD, Tatyana Gurvich, PharmD, BCGP, APh, and Patrick Tabon, PharmD, MPH, APh, BCPS, BCGP, BCACP

Click for Description & Learning Objectives

Description: In this presentation, we will discuss implementing age-friendly health systems and incorporating the four evidence-based elements: What Matters, Medication, Mentation, and Mobility. These elements are essential for providing patient-centered care to our geriatric patients, prioritizing their unique needs, and ensuring high-quality outcomes.

Learning Objectives:
1. Identify the 4M’s of age-friendly health systems.
2. Discuss resources utilized to develop an age-friendly health system.
3. Outline various roles pharmacists can play in age-friendly health systems.
4. Implement age-friendly health systems in practice.

Location: WILSHIRE A

1.0 CE Hour UAN: 0113-0000-24-022-L04-P; 0113-0000-24-022-L04-T
9:45 am
OPIOID/TRAUMA DISCHARGE COUNSELING: THE PROCESS, THE "PERCS", AND NALOXONE
Amber Miller, PharmD, and Erin Bess, PharmD

Click for Description & Learning Objectives

Description: Participants in this learning activity will gain insights on how to implement an opioid discharge counseling service at a community institution, including provision of naloxone in-hand upon discharge.

Learning Objectives:
1. Describe the current state of opioid discharge counseling and naloxone distribution at your institution.
2. Identify potential opportunities for a novel opioid discharge counseling and naloxone distribution program at your institution.
3. Develop a plan to create a successful opioid discharge counseling and naloxone in-hand program.
4. Measure possible institutional benefits derived from an opioid discharge counseling and naloxone in-hand program.

Location: SUNSET 5

1.0 CE Hour UAN: 0113-0000-24-023-L01-P; 0113-0000-24-023-L01-T
8:30 am
FINANCIAL LITERACY FOR THE YOUNG PRACTITIONER
Clifford Young, RPh, CGP

Click for Description & Learning Objectives

Description: This session is designed to get the young pharmacy student thinking about how to invest the fruits of their professional efforts and set them up for success in their financial pursuits. Knowing what is out there and getting a foundational plan together is what this session will achieve.

Learning Objectives:
1. Expose the participant to the nomenclature of things financial.
2. Understand that they CAN and MUST be the quarterback of their financial plan.
3. Provide a financial plan and foundation for the participant to establish immediately.
4. Stimulate further research on the topic.

Location: MELROSE 3

Share

About Our Blog

Iterative approaches to corporate strategy foster collaborative thinking to further the overall value proposition.
April 12-14, 2019
JW Marriott L.A. Live
900 Olympic Blvd, Los Angeles, CA 90015

Top Rated